Bendamustine, Bortezomib (Velcade) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Bendamustine (Primary) ; Bortezomib (Primary) ; Prednisone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 16 May 2016 Status changed from active, no longer recruiting to completed.
- 08 Apr 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 08 Apr 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History